PMA P210006S005

Device
Thoraflex Hybrid
Applicant
Vascutek, Ltd.
PMA number
P210006
Supplement
S005
Product code
QSK
Decision date
2023-11-20
Classification
Cardiovascular
Generic name
Hybrid stent graft, thoracic aortic lesion treatment
Approval order statement
Approval for a change in equipment used to manufacture the delivery system and a change in cleaning method for the stainless-steel shaft component of the delivery system.

Current openFDA PMA Record#

Device
Thoraflex Hybrid
Applicant
Vascutek, Ltd.
PMA number
P210006
Supplement
S005
Product code
QSK
Generic name
Hybrid stent graft, thoracic aortic lesion treatment
Decision date
2023-11-20
Decision code
APPR
Date received
2023-07-27
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Approval for a change in equipment used to manufacture the delivery system and a change in cleaning method for the stainless-steel shaft component of the delivery system.